Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy
| Autor: | Diéras, V. *, Limentani, S., Romieu, G., Tubiana-Hulin, M., Lortholary, A., Kaufman, P., Girre, V., Besenval, M., Valero, V. |
|---|---|
| Zdroj: | In Annals of Oncology July 2008 19(7):1255-1260 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|